STOCK PRICE

Quote






anonymous said:
When is the Town Hall meeting? I'm sure we will all be comforted and reassured by Mark and Co.
Click to expand...

Sadly, they fucked up the townhall as badly as they the earnings this quarter. No one is reassured or comforted.. what’s worse is that Mark and co. continue to make the same cliched statements over and over again expecting that all their problems will vanish.
 






This is it. This management team is done. They will hang around to receive a package when they get fired, but this is the end. Go find another job and watch this train wreck from a safe distance.
 






Doctor prescribes acthar=patient starts on acthar=patient experiences zero improvement=either doctor doesn’t refill or patient does not want refill as they are having to do injections without any benefit=unfilled prescriptions=Revenue loss=worthless and very expensive drug going extinct=where it was before questcor acquired=where it should be.

This is not rocket science folks!
 






anonymous said:
Doctor prescribes acthar=patient starts on acthar=patient experiences zero improvement=either doctor doesn’t refill or patient does not want refill as they are having to do injections without any benefit=unfilled prescriptions=Revenue loss=worthless and very expensive drug going extinct=where it was before questcor acquired=where it should be.

This is not rocket science folks!
Click to expand...


We know. Everyone knows and saw through their dog and pony show yesterday. That is why the stock was in a free fall afterwards.
 






I don't understand. I thought this product was doing well. It has been growing. Why all of a sudden did it slow down so much in 3Q17. Is it because compliance is more closely monitoring reps activity in the wake of Insys? Everyone seems to suggest that things have been bad for a while but Acthar sales have been pretty good up until 3Q17.
 






anonymous said:
I don't understand. I thought this product was doing well. It has been growing. Why all of a sudden did it slow down so much in 3Q17. Is it because compliance is more closely monitoring reps activity in the wake of Insys? Everyone seems to suggest that things have been bad for a while but Acthar sales have been pretty good up until 3Q17.
Click to expand...
I know it’s good for you to be getting some oxygen now after having your head buried in the sand since early 2017!
 






that lack of oxygen can also explain why investors still hold MNK and people still come to work. the only hope is a buy out. declining sales. patent issue. selling generics declines earning per share. gov agencies on the prowl. public opinion in the toilet. this will be a bschool case study.
 






anonymous said:
that lack of oxygen can also explain why investors still hold MNK and people still come to work. the only hope is a buy out. declining sales. patent issue. selling generics declines earning per share. gov agencies on the prowl. public opinion in the toilet. this will be a bschool case study.
Click to expand...

Yes it will. And unless someone can prove epic malfeasance on the scale of Enron these guys will all ride off into the sunset with big bags of money.
 






anonymous said:
I don't understand. I thought this product was doing well. It has been growing. Why all of a sudden did it slow down so much in 3Q17. Is it because compliance is more closely monitoring reps activity in the wake of Insys? Everyone seems to suggest that things have been bad for a while but Acthar sales have been pretty good up until 3Q17.
Click to expand...
Easy one. We have two insecure bald guys (HO and NM) who blame everyone but themselves. Drain the swamp!!
 






actually. they won’t walk with lots of money since stock is not worth much. maybe they will get decent severance. but that runs out in a year or two. many of them can’t get another job like they have again after this mess. some will have a long road ahead to get another job. nobody wins in this game. everyone loses. including those who need treatment other than Acthar and those who actually need Acthar. shareholders lose employees lose patients lose. lose lose lose. shameful
 






anonymous said:
actually. they won’t walk with lots of money since stock is not worth much. maybe they will get decent severance. but that runs out in a year or two. many of them can’t get another job like they have again after this mess. some will have a long road ahead to get another job. nobody wins in this game. everyone loses. including those who need treatment other than Acthar and those who actually need Acthar. shareholders lose employees lose patients lose. lose lose lose. shameful
Click to expand...
“Those who actually need acthar”? Why not just give them snakeoil, afterall it is the same thing.
 






Achtar is actually very beneficial drug and it is the last hope for many refractory patients. I understand a lot of you are pissed off about our stock price, but this is a temporary setback and we will stage a come back soon. Just have some faith...
 






What would give us faith is seeing the decision makers put skin in the game and move from their estates in Saint Louis to the office they set up in New Jersey. if they all have faith why did they not move?
 






anonymous said:
Achtar is actually very beneficial drug and it is the last hope for many refractory patients. I understand a lot of you are pissed off about our stock price, but this is a temporary setback and we will stage a come back soon. Just have some faith...
Click to expand...
“Very beneficial drug”?........only beneficial to your bonus check! Be honest for a change!
 






anonymous said:
What would give us faith is seeing the decision makers put skin in the game and move from their estates in Saint Louis to the office they set up in New Jersey. if they all have faith why did they not move?
Click to expand...

I would not recommend that considering that the MNK folks with estates in STL are likely to be fired soon.
 






Our “leaders”somehow believe, or being told by consultants, it would be easier to hire talent in the East, not accepting that the issue is not geography but the poor reputation of the company, our sinking stock price, and its executives.
 






the strategy to move to New Jersey and transform into a spec brands biz started after ipo from Covidian. the bod and people at top made bad decisions on how to transform. bought wrong companies hired wrong people and were cowards when heat was turned up hiding in Missouri while the results of their bad decisions blew up. the consultants have the right guidance these people just made bad decisions. there is a difference
 












Found out that Marky Mark bought some MNK shares... hope this is not a precedent for another stock buyback program. When will these guys learn that this has not worked in the past and will not work now!! We are fucked..
 






Top Bottom
Back
Quote